Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Thalassemia
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
Related Questions
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
